| 1. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 2. |  All India Institute of Medical Sciences, Raipur Raipur, India | Diagnostics | Commercial | VIEW |
| 3. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 4. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 5. |  Ami Organics Limited Surat, India | CDMO | Commercial | VIEW |
| 6. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 7. |  | Pharma | Discovery through Commercial | VIEW |
| 8. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 9. |  Blanchard Valley Health System Findlay, USA | MedTech | Commercial | VIEW |
| 10. |  | Digital Health | Commercial | VIEW |
| 11. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 12. |  CERNO Eeklo (Ghent region), Belgium | CRO | Commercial | VIEW |
| 13. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 14. |  Cambridge Consultants Cambridge, United Kingdom | MedTech | Commercial | VIEW |
| 15. |  | Digital Health | Commercial | VIEW |
| 16. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 17. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 18. |  China Medical University Hospital (CMUH) Taichung, Taiwan | Biotech | Phase 2 | VIEW |
| 19. |  Chinese Medical Association Publishing House (CMAPH) Beijing, China | Digital Health | Commercial | VIEW |
| 20. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 21. |  Chung-Ang University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 22. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 23. |  Cliantha Research Ahmedabad, India | CRO | Commercial | VIEW |
| 24. |  Corline Biomedical AB Uppsala, Sweden | Biotech | Phase 2 | VIEW |
| 25. |  Cuttsy+Cuttsy Cambridge, United Kingdom | CRO | N/A (Service Provider) | VIEW |
| 26. |  Cyborg Advisor New York, USA | Digital Health | Commercial | VIEW |
| 27. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 28. |  | CRO | Service Provider | VIEW |
| 29. |  CytoTools AG Heidelberg, Germany | Biotech | Phase 3 | VIEW |
| 30. |  Cytochroma Edinburgh, United Kingdom | Biotech | Discovery | VIEW |
| 31. |  | CRO | Commercial | VIEW |
| 32. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 33. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 34. |  | Pharma | Commercial | VIEW |
| 35. |  Fivos Health West Lebanon, New Hampshire | Digital Health | Not Applicable (Data Services Company) | VIEW |
| 36. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 37. |  Fosun Pharma Shanghai, China | Pharma | Commercial | VIEW |
| 38. |  GE HealthCare Chicago, USA (Global); Lindesnes/Oslo, Norway (PDx R&D/Manufacturing) | MedTech | Commercial | VIEW |
| 39. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 40. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 41. |  | CRO | Commercial | VIEW |
| 42. |  HDS Formación Barcelona, Spain | Digital Health | Commercial | VIEW |
| 43. |  Hone Bio Bristol, United Kingdom | Biotech | Preclinical | VIEW |
| 44. |  IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary) | CRO | N/A - Service Provider | VIEW |
| 45. |  Ionis Pharmaceuticals, Inc. Carlsbad, California, United States | Biotech | Phase 1 through Commercial | VIEW |
| 46. |  Laboratorios Bagó Buenos Aires, Argentina | Biotech | Commercial | VIEW |
| 47. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 48. |  Lifespan (now Brown University Health) Providence, USA | Pharma | Commercial | VIEW |
| 49. |  | CDMO | Commercial | VIEW |
| 50. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 51. |  Medical University of Silesia Katowice, Poland | Diagnostics | Commercial | VIEW |
| 52. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 53. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 54. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 55. |  Philips Amsterdam, Netherlands | MedTech | Commercial | VIEW |
| 56. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 57. |  SSM Health St. Louis, United States | Digital Health | Commercial | VIEW |
| 58. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 59. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 60. |  Tongji University Shanghai, China | Biotech | Phase 3 | VIEW |
| 61. |  U.S. Stem Cell, Inc. Sunrise, Florida, United States | Biotech | Clinical Development | VIEW |
| 62. |  UK Biobank Stockport, United Kingdom | Diagnostics | Commercial | VIEW |
| 63. |  Universitas Indonesia Depok, Indonesia | CRO | Phase 3 | VIEW |
| 64. |  Vandalia Health Charleston, United States | MedTech | Commercial | VIEW |
| 65. |  Vasa Therapeutics Encinitas, USA | Biotech | Phase 1 | VIEW |
| 66. |  Viatris Canonsburg, Pennsylvania, United States | Pharma | Phase 1 to Commercial | VIEW |